Saltra Hfa 25+125 Mcg Inhaler

Product Description

Product Name: Saltra Hfa 25+125 Mcg Inhaler

Product Form: Inhaler

Pack Size: 1's

Manufactured By: GETZ PHARMA PAKISTAN (PVT) LTD

Used For:

Saltra HFA 25+125 mcg Inhaler is a medication used for:

• Asthma: It is prescribed for the long-term management and prevention of asthma symptoms, including wheezing, shortness of breath, chest tightness, and coughing.
• Chronic Obstructive Pulmonary Disease (COPD): It may also be used to manage symptoms of COPD, including chronic bronchitis and emphysema.

The medication in Saltra HFA 25+125 mcg Inhaler is a combination of two active ingredients:

• Salbutamol (25 mcg): A short-acting beta2-adrenergic agonist (SABA) bronchodilator that works quickly to relax the muscles around the airways, making breathing easier.
• Fluticasone Propionate (125 mcg): A corticosteroid that reduces inflammation in the airways, helping to prevent asthma attacks and manage COPD symptoms.

Features:

• Metered-Dose Inhaler (MDI) Delivery: Administered through an MDI, which delivers a measured dose of medication with each inhalation.
• Combination Therapy: Provides the benefits of both a bronchodilator and a corticosteroid in one inhaler.
• Maintenance and Relief: Can be used for both daily maintenance therapy to prevent symptoms and as a reliever during acute asthma attacks or exacerbations.
• Quick Onset of Action: Salbutamol provides rapid relief of bronchospasm, helping to open the airways quickly.
• Convenient Dosage: The 25+125 mcg strength provides a standard dose of salbutamol and fluticasone propionate in each inhalation, simplifying dosing for patients.

Side Effects:

Common side effects may include:

• Throat irritation or hoarseness
• Oral thrush (fungal infection in the mouth)
• Cough
• Headache
• Tremor
• Palpitations

Less common but more serious side effects may include:

• Increased heart rate (tachycardia)
• High blood pressure (hypertension)
• Bone thinning (osteoporosis) with long-term use
• Suppression of adrenal gland function

Precautions:

To ensure safe and effective use of Saltra HFA 25+125 mcg Inhaler, consider the following precautions:

• Consultation: Discuss your medical history and any existing conditions with your healthcare provider before starting this medication.
• Proper Use: Learn and follow the correct inhalation technique to ensure that the medication reaches the lungs effectively.
• Regular Monitoring: Attend follow-up appointments with your healthcare provider to monitor your response to the medication and adjust treatment as needed.
• Long-Term Use: Long-term use of corticosteroids may require monitoring for potential side effects such as bone thinning, cataracts, or adrenal suppression.
• Asthma Action Plan: Develop an asthma action plan with your healthcare provider to manage asthma symptoms and exacerbations effectively.
• Emergency Care: Have a rescue inhaler (e.g., short-acting beta-agonist) available for acute asthma attacks or worsening symptoms.